As of the July 5, 2022, data cutoff, early CNM-Au8® treatment resulted in a significant survival benefit (5 CNM-Au8 deaths vs. 14 placebo deaths, HR=0.301, p=0.0143) CNM-Au8 treatment was ...
How to easily open files with sudo privileges in the GNOME File Manager Your email has been sent Not all Linux file managers are created equal. Some file managers have more bells and whistles than the ...
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and ...
Clinical trials are vital for the design and development of safe drugs, treatments, and medical interventions and bringing them to market. Often, the idea for a clinical trial starts in the laboratory ...
Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Atai Beckley BPL-003 phase IIb open-label extension ...
MONTREAL — An open-label extension study of subcutaneous efgartigimod PH20 to treat chronic inflammatory demyelinating polyneuropathy (CIDP) showed durability of functional improvements to week 24, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback